Population Based Testing for Cancer Susceptibility Genes
Thursday, November 12th,12 PM EST
*Please note this webinar has already taken place, to view on demand click on the below link and enter passcode.
Access Passcode: J&+5Uf7A
Presented by: Oneinforty and Yodeah
This free webinar is open to all healthcare providers and medical professionals who want to learn more about hereditary cancers and population-based testing for BRCA and other cancer susceptibility genes.
Program Description: Hereditary pathogenic variants on cancer susceptibility genes such as BRCA can increase a patient's lifetime risk of cancer. Identifying patients who carry these pathogenic variants is essential as there are established, effective guidelines for reducing cancer burden through chemoprevention, increased surveillance and risk reduction surgery.
The link between Ashkenazi Jewish ancestry and an increased prevalence of BRCA mutations has been noted in scientific literature for many years. In December 2019, the National Comprehensive Cancer Network expanded their guidelines to "consider testing of all Ashkenazi Jewish men and women if they have one of four Ashkenazi Jewish grandparents, irrespective of family history."
Join leading medical experts and scientific investigators as we discuss the pivotal data that support the guideline change, and discuss other high prevalent populations. We will also discuss population-based testing for BRCA and other cancer susceptibility genes as a means of decreasing ovarian cancer burden.
Elizabeth Etkin-Kramer, MD, FACOG
Board-Certified Gynecologist, Miami, FL
Assistant Professor, Obstetrics and Gynecology, FIU Herbert Wertheim School of Medicine, Miami, FL
American College of Obstetrics of Gynecology, Presidential Task Force – 2020
Ephrat Levy-Lahad, MD
Director, Medical Genetics Institute, Shaare Zedek Medical Center
Professor, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem Israel
Ranjit Manchanda, MD, MRCOG, PhD
Professor of Gynecological Oncology, Wolfson Institute of Preventive Medicine, Queen Mary University of London
Consultant Gynecological Oncologist, Barts Health NHS Trust, London, UK
NHS Innovation Accelerator (NIA) Fellow
Integrated Academic Training Program Director, London Specialty School of Obstetrics & Gynecology, Health Education England
Sophia George, PhD
Department of Obstetrics, Gynecology and Reproductive Sciences
Division of Gynecologic Oncology
Sylvester Comprehensive Cancer Center
University of Miami Miller School of Medicine
Yodeah’s mission is to educate and facilitate cost-effective testing for hereditary cancer genetic mutations in the Jewish community.